Stock·NASDAQ·Technology
Axcelis Technologies Inc. (ACLS)
- Market cap
- $3.37B
- P/E
- 36.61
- Dividend yield
- None
- Street target
- $145.00median of 5 analysts
- 52-week range
- $73.60 $193.78
ACLS stock forecast today
Where ACLS stands today, and what CleaRank Financial AI makes of it.
ACLS at a glance
Axcelis Technologies Inc. (ACLS): Hold, 49/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($120.34 and $122.83).
- Earnings ACLS beat estimates in 7 of the 7 reports in our data, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $6.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 36.6 against 35.1 for the Technology sector: broadly in line with peers (+4%).
Figures as of October 26, 2026.
CleaRank Financial AI
Axcelis Technologies Inc. (ACLS) receives a Hold rating from CleaRank, with a model score of 49/100.
Its earnings record adds the most to that score, with estimates beaten in 7 of the 7 reports in our data and the latest report beating the estimate by 19.10%. The trend subtracts the most: the price is 11.17% below its 200-day average and 9.33% below its 50-day average, and the 50-day average is 2.03% below the 200-day. The two averages stand at $120.34 and $122.83, and over the past year the price rose 30.97%.
Only on CleaRank
Figures we compute ourselves from ACLS's own price, earnings and insider-filing history. Tap one to see it in context.
ACLS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $109.11 is 9.3% below the 50-day simple moving average of $120.34.Price above its 200-day average ›
The price is 11.2% below the 200-day simple moving average of $122.83.50-day average above the 200-day ›
The 50-day average ($120.34) is 2.0% below the 200-day average ($122.83), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 30% of its 52-week range, between $73.60 and $193.78.
ACLS share price
Pick a period: each tab shows how far ACLS has moved over it, to the last close.
Today's trading
Where ACLS sits inside today's range and its 52-week range.
ACLS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 36.61 is 4.3% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 3.89 is 48.8% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $92.8M on revenue of $866.1M, a net margin of 10.7%.Beat estimates in most recent reports ›
ACLS beat the EPS estimate in 7 of the 7 reports in our data.
Key statistics
The headline figures for ACLS.
As of October 26, 2026, ACLS trades at $109.11, with a market value of $3.37B and a P/E ratio of 36.61.
What the numbers say
CleaRank Financial AI's reading of ACLS's valuation, growth and risks.
On earnings, Axcelis Technologies Inc. (ACLS) is valued at 35.77 times, against a median of 35.1 for Technology: broadly in line with peers, with the P/E 1.9% above that median. On sales, the P/S of 3.89 compares with a sector median of 7.6, 50.0% below it. ACLS has a market value of $3.4B.
In the latest quarter, against the same quarter a year earlier, revenue grew 10.60%, 13.6 percentage points slower than the sector median of 24.2%. Profitability shows a net margin of 10.71% and an operating margin of 9.43%, with a return on equity of 8.89%, below the sector median of 13.4%. Debt-to-equity of 0.07 rounds out the fundamentals.
Axcelis Technologies Inc. (ACLS) posted EPS of $1.06 in its August 6, 2026 report, ahead of the $0.89 analysts had expected, a beat of 19.10%. The share price moved up 2.64% in the next session.
Across the 7 reports in our data, ACLS beat the estimate every time, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Analysts' average EPS estimate for this fiscal year is $4.11, which would be a decline of 15.9%, and $5.27 for next year (growth of 28.3%).
Normal swings for ACLS run at about 3.94% a day, and its beta against the S&P 500 is 1.85. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 43.69% below its 52-week high of $193.78. Over the last 18 months, insider sales totalled $6.5M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
ACLS against the Technology sector
How ACLS compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (4% difference), suggesting fair market pricing relative to industry standards.
Return vs XLK: Since May 14, 2025, ACLS has gained 73.9% against a gain of 59.2% for XLK.
Performance against XLK
ACLS and the Technology sector fund over the same days.
Revenue and earnings
How much ACLS sells, and how much of it becomes profit.
Revenue growth: Revenue fell 17.6% in FY2025 to $839M, from $1.0B a year earlier.
Profit margin: The net margin was 14.3% in FY2025, down from 19.7% the year before.
Profitable: ACLS earned $120M in FY2025.
Earnings reality check
Did ACLS beat what analysts expected, and how did the stock react?
Earnings record: ACLS beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $0.89 | $1.06 | +19.10% | +2.64% | +4.66% |
| May 7, 2026after close | $0.71 | $0.72 | +1.41% | +2.75% | +1.88% |
| Nov 4, 2025after close | $1.00 | $1.21 | +21.00% | +4.89% | +6.30% |
| Aug 5, 2025after close | $0.71 | $1.13 | +59.15% | -2.94% | +4.24% |
| May 6, 2025after close | $0.38 | $1.04 | +173.68% | +6.20% | +14.94% |
| Feb 10, 2025after close | $1.25 | $1.54 | +23.20% | -12.25% | -6.10% |
| Nov 6, 2024after close | $1.43 | $1.49 | +4.20% | -0.97% | -9.36% |
As of October 26, 2026, ACLS has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on August 6, 2026, came in 19.10% above the estimate and the stock moved +2.64% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
ACLS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 40.6, in neutral territory.RSI above 50 ›
An RSI of 40.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of ACLS
The score, the reasoning behind it, and what could move the price next.
ACLS is in a downtrend: both of its moving averages sit above the price. The price of $109.11 trades 9.33% below the 50-day average of $120.34 and 11.17% below the 200-day average of $122.83. Sitting at 30% of its 52-week range, the price stands 48.25% above the 52-week low of $73.60. The two averages point the same way, with the 50-day 2.03% below the 200-day.
A recent pullback sits inside a stronger longer record: the price fell 11.37% over the past month, fell 14.83% over the past three months and rose 30.97% over the past year. On momentum, the 14-day RSI reads 40.6, in the neutral zone, with the MACD line negative.
Earnings beat ›
The August 6, 2026 report beat the EPS estimate by 19.10%, and the share price rose 2.64% in the first session after it.
Source: Earnings report, August 6, 2026
Rating reaffirmed ›
B of A Securities kept its Underperform rating on June 23, 2026.
Source: Analyst action, B of A Securities, June 23, 2026
- Watch the two nearest levels: the 20-day EMA at $117.93 above the price and the 52-week low at $73.60 below it.
- The 14-day RSI reads 40.6, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- In the first session after the August 6, 2026 report, the share price rose 2.64%. Across the 7 reports in our data, ACLS has beaten estimates in 7 of 7.
ACLS remains in a downtrend while it trades below both its 50-day average of $120.34 and its 200-day average of $122.83. A move back above the 50-day average would be the first sign of repair. Overhead, the 20-day EMA at $117.93 is the first level the price would need to clear.
ACLS has its next level below at the 52-week low of $73.60.
Technical indicators
Momentum and trend for ACLS, from its daily closes.
As of October 26, 2026, with ACLS at $109.11, its 14-day RSI is 40.6 (neutral territory), its 50-day simple moving average is $120.34 and its 200-day is $122.83.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ACLS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, ACLS's 1-year correlation of daily returns is +0.52 with S&P 500 (SPY), +0.60 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.11 with gold (XAU).
ACLS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
1 of 5 analysts rate it a buy or strong buy, 3 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $145.00 is 32.9% above the price.More buy ratings than three months ago ›
1 of 5 rate it a buy now, against 2 of 5 three months ago.
ACLS Wall Street View
12-month price targets
The price, $109.11, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 23, 2026 | B of A Securities | Maintains | Underperform |
As of October 26, 2026, 5 Wall Street analysts cover ACLS: 1 rate it a buy or strong buy, 3 a hold and 1 a sell or strong sell. Their 12-month price targets range from $140.00 to $198.00. The median ACLS price target is $145.00, 32.9% above the price of $109.11.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ACLS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ACLS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
ACLS moves about 3.9% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ACLS tends to move, against the market and on its own.
ACLS price history and drawdowns
ACLS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 3.94% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 77.6%, from August 2023 to April 2025, regained by June 2026.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $82,038, against $42,015 in the S&P 500 (SPY).
ACLS Drawdowns & Recovery
As of October 26, 2026, ACLS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -77.6% (August 2023 to April 2025); it regained that peak by June 2026, 14 months after the low, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ACLS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ACLS beat the S&P 500 over this period: $82,038 against $42,015.
A $10,000 investment in ACLS in October 2016 would be worth about $82,038 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ACLS, and which have not.
Strongest month, November: an average of +7.42%, up in 6 of 10 years.
Weakest month, October: an average of -3.52%, up in 4 of 9 years.
This month, October: has averaged -3.52%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ACLS's strongest calendar month has been November (average +7.42%, up in 6 of 10 years) and its weakest October (average -3.52%, up in 4 of 9 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
ACLS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ACLS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in ACLS today could grow to about $15,033 by 2030 in the base case, with a 90th-percentile outcome near $54,155 and a 10th-percentile outcome around $4,173. Projections are statistical simulations, not guarantees.
ACLS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $164 for ACLS by 2030 in the base case, from $109 today (1.5x over 4 years). The 10th-percentile path ends near $45.53. These are outcomes of a Monte Carlo simulation run on ACLS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $63.65 | $121 | $229 | |
| 2028 | $54.05 | $134 | $331 | |
| 2029 | $48.82 | $148 | $449 | |
| 2030 | $45.53 | $164 | $591 |
Method: a lognormal simulation of ACLS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ACLS is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
ACLS insider trading
What the people running the company have bought and sold.
ACLS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought ACLS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, ACLS insiders reported 23 open-market sales worth $6.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Necip Sayiner
Director
|
Sell | 1.6K | $249.7K |
| Jun 2, 2026 | Robert John Mahoney
Officer
|
Sell | 1.2K | $179.3K |
| May 27, 2026 | Todd Sutton
Officer
|
Sell | 2.0K | $320.0K |
| May 22, 2026 | Eileen Evans
General Counsel
|
Sell | 926 | $144.0K |
| May 22, 2026 | Dennis Thomas St
Director
|
Sell | 900 | $139.8K |
| May 21, 2026 | Gerald M Blumenstock
Officer
|
Sell | 1.2K | $177.3K |
| May 20, 2026 | Christopher Tatnall
Officer
|
Sell | 1.2K | $174.6K |
| May 19, 2026 | John Thomas Kurtzweil
Director
|
Sell | 3.5K | $485.8K |
| May 19, 2026 | Gregory B Graves
Director
|
Sell | 3.2K | $456.7K |
| May 19, 2026 | Jeanne Quirk
Director
|
Sell | 1.8K | $250.9K |
| May 15, 2026 | Gerald M Blumenstock
Officer
|
Grant | 5.5K | - |
| May 15, 2026 | Tzu Yin Chiu
Director
|
Grant | 1.4K | - |
| May 15, 2026 | Eileen Evans
General Counsel
|
Grant | 7.8K | - |
| May 15, 2026 | Gregory B Graves
Director
|
Grant | 1.4K | - |
| May 15, 2026 | John Thomas Kurtzweil
Director
|
Grant | 1.4K | - |
| May 15, 2026 | Russell J Low
Chief Executive Officer
|
Grant | 38.9K | - |
| May 15, 2026 | Robert John Mahoney
Officer
|
Grant | 3.9K | - |
| May 15, 2026 | Jeanne Quirk
Director
|
Grant | 1.4K | - |
| May 15, 2026 | Gregory F Redinbo
Officer
|
Grant | 6.2K | - |
| May 15, 2026 | David Ryzhik
Chief Financial Officer
|
Grant | 3.1K | - |
| May 15, 2026 | Necip Sayiner
Director
|
Grant | 1.4K | - |
| May 15, 2026 | Dennis Thomas St
Director
|
Grant | 1.4K | - |
| May 15, 2026 | Todd Sutton
Officer
|
Grant | 1.2K | - |
| May 15, 2026 | Christopher Tatnall
Officer
|
Grant | 7.0K | - |
| May 15, 2026 | Jorge Luis Titinger
Director
|
Grant | 1.4K | - |
| May 14, 2026 | Todd Sutton
Officer
|
Sell | 2.6K | $421.9K |
| May 14, 2026 | Gerald M Blumenstock
Officer
|
Sell | 1.0K | $164.8K |
| May 13, 2026 | Gregory F Redinbo
Officer
|
Sell | 2.9K | $463.7K |
| May 13, 2026 | Jorge Luis Titinger
Director
|
Sell | 2.0K | $328.3K |
| May 12, 2026 | Robert John Mahoney
Officer
|
Sell | 2.3K | $363.5K |
| May 6, 2026 | Russell J Low
Chief Executive Officer
|
Sell | 7.5K | $1.2M |
| May 1, 2026 | Russell J Low
Chief Executive Officer
|
Sell | 1.2K | $172.7K |
| Apr 1, 2026 | Russell J Low
Chief Executive Officer
|
Sell | 1.2K | $117.0K |
| Mar 24, 2026 | Russell J Low
Chief Executive Officer
|
Sell | 1.2K | $112.0K |
| Feb 20, 2026 | Jorge Luis Titinger
Director
|
Sell | 1.0K | $80.0K |
| Jan 15, 2026 | Robert John Mahoney
Officer
|
Grant | 1.7K | - |
| Dec 17, 2025 | Jorge Luis Titinger
Director
|
Sell | 2.0K | $172.1K |
| Dec 11, 2025 | Gerald M Blumenstock
Officer
|
Sell | 3.0K | $271.4K |
| May 20, 2025 | John Thomas Kurtzweil
Director
|
Sell | 1.7K | $104.2K |
| May 15, 2025 | Gerald M Blumenstock
Officer
|
Grant | 12.3K | - |
| May 15, 2025 | Tzu Yin Chiu
Director
|
Grant | 3.6K | - |
| May 15, 2025 | James Gordon Coogan
Chief Financial Officer
|
Grant | 24.6K | - |
| May 15, 2025 | Eileen Evans
General Counsel
|
Grant | 14.3K | - |
| May 15, 2025 | Gregory B Graves
Director
|
Grant | 3.6K | - |
| May 15, 2025 | John Thomas Kurtzweil
Director
|
Grant | 3.6K | - |
| May 15, 2025 | Russell J Low
Chief Executive Officer
|
Grant | 61.5K | - |
| May 15, 2025 | Jeanne Quirk
Director
|
Grant | 3.6K | - |
| May 15, 2025 | Gregory F Redinbo
Officer
|
Grant | 12.3K | - |
| May 15, 2025 | Necip Sayiner
Director
|
Grant | 3.6K | - |
| May 15, 2025 | Dennis Thomas St
Director
|
Grant | 3.6K | - |
| May 15, 2025 | Christopher Tatnall
Officer
|
Grant | 12.3K | - |
| May 15, 2025 | Jorge Luis Titinger
Director
|
Grant | 3.6K | - |
Source: TwelveData, from SEC Form 4 filings
ACLS stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.